Search Results - "De Benedittis, Caterina"
-
1
Ponatinib as a Valid Alternative Strategy in Patients with Blast Crisis-Chronic Myeloid Leukemia Not Eligible for Allogeneic Stem Cells Transplantation and/or Conventional Chemotherapy: Report of a Case
Published in Case reports in hematology (01-01-2017)“…Currently, imatinib and dasatinib are the only tyrosine-kinase inhibitors approved in the US and Europe for the treatment of blast crisis of chronic myeloid…”
Get full text
Journal Article -
2
Radiomics of cholangiocarcinoma on pretreatment CT can identify patients who would best respond to radioembolisation
Published in European radiology (01-08-2020)“…Objectives Results after trans-arterial radioembolisation (TARE) for intrahepatic cholangiocarcinoma (iCC) depend on the architecture of the tumour. This…”
Get full text
Journal Article -
3
Unraveling the complexity of tyrosine kinase inhibitor–resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain
Published in Blood (29-08-2013)“…In chronic myeloid leukemia and Philadelphia chromosome–positive acute lymphoblastic leukemia, tyrosine kinase inhibitor (TKI) therapy may select for…”
Get full text
Journal Article -
4
Mutations in the BCR-ABL1 Kinase Domain and Elsewhere in Chronic Myeloid Leukemia
Published in Clinical lymphoma, myeloma and leukemia (01-06-2015)“…Abstract Chronic myeloid leukemia (CML) has been the first human malignancy to be associated, more than 50 years ago, with a consistent chromosomal…”
Get full text
Journal Article -
5
-
6
Survival and Tolerability of Transarterial Chemoembolization in Greater Versus less than 70 Years of Age Patients with Unresectable Hepatocellular Carcinoma: A Propensity Score Analysis
Published in Cardiovascular and interventional radiology (01-07-2020)“…Background The number of elderly patients diagnosed with hepatocellular carcinoma (HCC) is progressively increasing. The aim of this study was to determine the…”
Get full text
Journal Article -
7
Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients
Published in Oncotarget (19-04-2016)“…In chronic myeloid leukemia (CML) and Philadelphia-positive (Ph+) acute lymphoblastic leukemia (ALL) patients who fail imatinib treatment, BCR-ABL1 mutation…”
Get full text
Journal Article -
8
FOXM1 Transcription Factor: A New Component of Chronic Myeloid Leukemia Stem Cell Proliferation Advantage
Published in Journal of cellular biochemistry (01-11-2017)“…ABSTRACT FOXM1 transcription factor is a central component of tumor initiation, growth, and progression due to its multiple effects on cell cycle, DNA repair,…”
Get full text
Journal Article -
9
The Heterogeneity of Skewness in T2W-Based Radiomics Predicts the Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
Published in Diagnostics (Basel) (28-04-2021)“…Our study aimed to investigate whether radiomics on MRI sequences can differentiate responder (R) and non-responder (NR) patients based on the tumour…”
Get full text
Journal Article -
10
14-3-3 Binding and Sumoylation Concur to the Down-Modulation of β-catenin Antagonist chibby 1 in Chronic Myeloid Leukemia
Published in PloS one (06-07-2015)“…The down-modulation of the β-catenin antagonist Chibby 1 (CBY1) associated with the BCR-ABL1 fusion gene of chronic myeloid leukemia (CML) contributes to the…”
Get full text
Journal Article -
11
Calreticulin: Challenges Posed by the Intrinsically Disordered Nature of Calreticulin to the Study of Its Function
Published in Frontiers in cell and developmental biology (23-11-2017)“…Calreticulin is a Ca -binding chaperone protein, which resides mainly in the endoplasmic reticulum but also found in other cellular compartments including the…”
Get full text
Journal Article -
12
Classification Performance for COVID Patient Prognosis from Automatic AI Segmentation—A Single-Center Study
Published in Applied sciences (01-06-2021)“…Background: COVID assessment can be performed using the recently developed individual risk score (prediction of severe respiratory failure in hospitalized…”
Get full text
Journal Article -
13
The clonal evolution of two distinct T315I-positive BCR-ABL1 subclones in a Philadelphia-positive acute lymphoblastic leukemia failing multiple lines of therapy: a case report
Published in BMC cancer (05-08-2017)“…The treatment of Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL) patients who harbor the T315I BCR-ABL1 mutation or who have two or…”
Get full text
Journal Article -
14
Best Practices in Chronic Myeloid Leukemia Monitoring and Management
Published in The oncologist (Dayton, Ohio) (01-05-2016)“…Optimal use of current therapeutic opportunities for chronic myeloid leukemia patients requires integration of clinical and laboratory monitoring. Assessment…”
Get full text
Journal Article -
15
Present and future of molecular monitoring in chronic myeloid leukaemia
Published in British journal of haematology (01-05-2016)“…Summary Currently, physicians treating chronic myeloid leukaemia (CML) patients can rely on a wide spectrum of therapeutic options: the best use of such…”
Get full text
Journal Article -
16
Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study
Published in Blood (20-02-2020)“…In chronic myeloid leukemia (CML) patients, tyrosine kinase inhibitors (TKIs) may select for drug-resistant BCR-ABL1 kinase domain (KD) mutants. Although…”
Get full text
Journal Article -
17
Drug resistance and BCR‐ABL kinase domain mutations in Philadelphia chromosome–positive acute lymphoblastic leukemia from the imatinib to the second‐generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the frequency of mutation involvement
Published in Cancer (01-04-2014)“…BACKGROUND Patients with Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia (ALL) frequently relapse on imatinib with acquisition of BCR‐ABL…”
Get full text
Journal Article -
18
Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phase
Published in Journal of cancer research and clinical oncology (01-05-2015)“…Purpose Here, we studied whether amplicon next-generation deep sequencing (NGS) could improve the detection of emerging BCR - ABL1 kinase domain mutations in…”
Get full text
Journal Article -
19
Transarterial radioembolization in patients with hepatocellular carcinoma of intermediate B2 substage
Published in European journal of nuclear medicine and molecular imaging (01-03-2019)“…Purpose Patients with hepatocellular carcinoma (HCC) of intermediate stage (BCLC-B according to the Barcelona Clinic Liver Cancer classification) are a…”
Get full text
Journal Article -
20
Diagnostic Accuracy of North America Expert Consensus Statement on Reporting CT Findings in Patients Suspected of Having COVID-19 Infection: An Italian Single-Center Experience
Published in Radiology. Cardiothoracic imaging (01-08-2020)“…To evaluate the diagnostic accuracy of the four standardized categories for CT reporting proposed by the Radiological Society of North America (RSNA) to…”
Get full text
Journal Article